is tirzepatide coming off the shortage list Eli Lilly's FDA's drug list: Here's what it means Out of Shortage, Into Controversy:

While Eli Lilly and Company has warning labels about the most common side effects of their GIP/GLP-1 medications, the language on these labels may not have provided adequate warnings about serious GI health risks such as stomach paralysis, intestinal blockages, bowel obstruction, or frequent and excessive vomiting

Recognizing the signs of incorrect semaglutide administration can help patients identify technique errors and make necessary adjustments

[1] While "bloating" specifically is not listed as a named adverse reaction in the FDA prescribing information, related gastrointestinal symptoms are well-documented with this medication class

The discomfort dropped from maybe a 7 out of 10 to something more manageable, around a 2 or 3 on bad days

effects on selenoprotein

Assessment of tissue fluid histamine levels in patients with urticaria